Content about Diethylcathinone

October 25, 2011
Lannett gets OK for generic anti-obesity drug

Lannett has received approval from the Food and Drug Administration to market its version of an anti-obesity drug.

PHILADELPHIA — Lannett has received approval from the Food and Drug Administration to market its version of an anti-obesity drug.

The FDA approved Lannett's abbreviated new drug application for diethylpropion hydrochloride extended-release tablets in the 75-mg strength. The company expects to begin shipping the product immediately.

October 17, 2011
Lannett begins shipping three generic drugs

Lannett announced that it has begun shipping three generic drugs that recently were approved by the Food and Drug Administration.

PHILADELPHIA — Lannett announced that it has begun shipping three generic drugs that recently were approved by the Food and Drug Administration.

The generic drug maker said that it has shipped diethylpropion tablets in the 25-mg strength; phentermine hydrochloride capsules in the 37.5-mg strength and loxapine capsules in 5-mg, 10-mg, 25-mg and 50-mg strengths.